Group Benefits from Global Diversification in a Challenging Environment

Group generated net sales of € 5.3 billion in the first quarter of 2023.

Key facts and Forecast

Results of Q1 2023   

  • Group net sales rise by 1.8% to € 5.3 billion  
  • New Healthcare products major growth drivers  
  • EBITDA pre down -2.6% to € 1.6 billion
  • Medium-term structural growth drivers intact 

Forecast for fiscal 2023   

  • Net sales: organic growth of 1% to 4%
  • Net sales excluding Covid-19-related business: organic increase of 4% to 7%
  • EBITDA pre: organic decline of ‑5% to stable at 0%
  • Negative foreign exchange effects on net sales and EBITDA pre of ‑5% to ‑2% expected

OVERVIEW: BUSINESS PERFORMANCE IN Q1 2023

 

Q1 2023              
(in € billion)

Change (in %, compared to Q1 2022)

Organic growth (in %, compared to Q1 2022)

Group net sales

5.3

1.8

0.8

EBITDA pre

1.6

-2.6

-1.7

Life Science sales

2.5

1.7

0.6

Healthcare sales

1.9

6.2

5.3

Electronics sales

0.9

-5.9

-7.1

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

2023 will be a transition year for us. But our structural growth drivers remain intact.

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Recordings & Conference calls for the media and analysts

The conference call for the media and the conference call for analysts are available as a recording.

Related News

View All News
  1. Press Releases

    Q1 Results: Merck KGaA, Darmstadt, Germany, Benefits from Global Diversification ...

    Merck KGaA, Darmstadt, Germany generated net sales of € 5.3 billion in the first quarter of 2023. This corresponds to an increase of 1.8% over the year-earlier quarter (organically 0.8%).

    2023/05/11

Upcoming Events

View All Events

Esther Döringer

Media Relations

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price